Alimetrix, Inc.

UEI
C7ESKJ8FU1Z7
CAGE
96K43
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
alimetrix.com
Founded
2015
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant subawards

Prime recipient Prime award Amount Awarded
University Of South Florida Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young U01DK128847 $1,134,908
University Of South Florida Limited Competition: Continued Follow-up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young… U01DK128847 $167,948
University Of South Florida Limited Competition: Continued Follow-Up of Subjects and Initiation of a Second Case-control Cohort in The Environmental Determinants of Diabetes in The Young… U01DK128847 $966,960

Similar vendors

About the company

Alimetrix, Inc. operates exclusively as a subrecipient on federal research grants, with all three recent awards flowing through the University of South Florida as the prime recipient on a National Institutes of Health grant program focused on diabetes epidemiology and environmental determinants.

Alimetrix is a for-profit corporate entity based on the available designation data. The vendor has no prime contract or grant footprint in the source; all activity is subaward work under a single prime grantee. Over the past two years, Alimetrix has received three subaward notices from the Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), each time as a subrecipient beneath the University of South Florida. The three awards, dated May 7, 2025, September 22, 2025, and March 16, 2026, all support continued follow-up and cohort expansion within the Environmental Determinants of Diabetes in The Young (TEDDY) study, a longitudinal epidemiological investigation tracking environmental and genetic risk factors for diabetes onset in children. Combined obligated value across the three subawards is $2.3 million.

The vendor's federal footprint is narrow and concentrated. Alimetrix serves a single customer agency (NIDDK) through a single prime relationship (University of South Florida), with award velocity holding at one to two subawards per year. No recompete cliff or vehicle position data is available; the source does not indicate whether Alimetrix holds any seats on government-wide IDIQs or parent vehicles. The subaward descriptions do not specify the nature of Alimetrix's contribution to the TEDDY study — whether the company provides data management, biostatistical analysis, participant recruitment and follow-up coordination, laboratory services, or research administration support — only that it operates as a research subcontractor within the University of South Florida's prime grant.

SBA capabilities narrative

Alimetrix is a diagnostic laboratory which specializes in the diagnosis of infectious diseases by microarray based polymerase chain reaction (PCR) and next generation sequencing (NGS) technology and . Our methods are able to detect DNA and RNA from bacteria, mycobacteria, fungi, unicellular parasites, and multicellular parasites from both body fluids and tissue. We are able to antimicrobial detect resistance genes to antibacterial, antifungal, and antiviral agents. We are also able to detect genes coding for microbial virulence factors. Our technology is easily modifiable to oncology applications looking for human genes .

Quick answers

Is Alimetrix, Inc. registered in SAM.gov?

Alimetrix, Inc.'s SAM.gov registration expired on April 17, 2026.

On GovTribe

See Alimetrix, Inc.'s full federal record

  • Similar vendors